However, such overactivation has been previously reported in AD, likely caused by the binding of oAβ to insulin receptors, which inhibits the PI3K/Akt pathway, preventing Akt from inactivating GSK-3β [101]. The gene discussed is AKT1; the disease is Alzheimer disease.